Lilly Analyzes Medicare Rx; Medicaid Changes May Be Big Plus

The transfer of seniors who currently receive drug benefits under Medicaid into the new Medicare drug benefit may mean that private managed care purchasers will have enhanced leverage in price negotiations with manufacturers, Lilly CEO Sidney Taurel suggested